来自MSN

Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product

Philip Morris International (NYSE:PM) is urging the U.S. Food and Drug Administration to allow the company to continue marketing its heated tobacco products in the U.S. as a “modified risk tobacco ...
JSTOR Daily

Modelling the impact of a new tobacco product: review of Philip Morris International’s ...

ObjectivesWe review the Population Health Impact Model (PHIM) developed by Philip Morris International and used in its application to the US Food and Drug Administration (FDA) to market its heated ...
来自MSN

Philip Morris Seeks FDA Approval To Keep IQOS Modified Risk Designation For Later Versions ...

Philip Morris International Inc. (PM) said on Wednesday that its experts met with the Tobacco Products Scientific Advisory Committee on October 7 as it seeks to continue marketing versions of its IQOS ...